Cargando…
Radiomics in Oncological PET Imaging: A Systematic Review—Part 2, Infradiaphragmatic Cancers, Blood Malignancies, Melanoma and Musculoskeletal Cancers
The objective of this review was to summarize published radiomics studies dealing with infradiaphragmatic cancers, blood malignancies, melanoma, and musculoskeletal cancers, and assess their quality. PubMed database was searched from January 1990 to February 2022 for articles performing radiomics on...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9222024/ https://www.ncbi.nlm.nih.gov/pubmed/35741139 http://dx.doi.org/10.3390/diagnostics12061330 |
_version_ | 1784732771208396800 |
---|---|
author | Morland, David Triumbari, Elizabeth Katherine Anna Boldrini, Luca Gatta, Roberto Pizzuto, Daniele Annunziata, Salvatore |
author_facet | Morland, David Triumbari, Elizabeth Katherine Anna Boldrini, Luca Gatta, Roberto Pizzuto, Daniele Annunziata, Salvatore |
author_sort | Morland, David |
collection | PubMed |
description | The objective of this review was to summarize published radiomics studies dealing with infradiaphragmatic cancers, blood malignancies, melanoma, and musculoskeletal cancers, and assess their quality. PubMed database was searched from January 1990 to February 2022 for articles performing radiomics on PET imaging of at least 1 specified tumor type. Exclusion criteria includd: non-oncological studies; supradiaphragmatic tumors; reviews, comments, cases reports; phantom or animal studies; technical articles without a clinically oriented question; studies including <30 patients in the training cohort. The review database contained PMID, first author, year of publication, cancer type, number of patients, study design, independent validation cohort and objective. This database was completed twice by the same person; discrepant results were resolved by a third reading of the articles. A total of 162 studies met inclusion criteria; 61 (37.7%) studies included >100 patients, 13 (8.0%) were prospective and 61 (37.7%) used an independent validation set. The most represented cancers were esophagus, lymphoma, and cervical cancer (n = 24, n = 24 and n = 19 articles, respectively). Most studies focused on 18F-FDG, and prognostic and response to treatment objectives. Although radiomics and artificial intelligence are technically challenging, new contributions and guidelines help improving research quality over the years and pave the way toward personalized medicine. |
format | Online Article Text |
id | pubmed-9222024 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-92220242022-06-24 Radiomics in Oncological PET Imaging: A Systematic Review—Part 2, Infradiaphragmatic Cancers, Blood Malignancies, Melanoma and Musculoskeletal Cancers Morland, David Triumbari, Elizabeth Katherine Anna Boldrini, Luca Gatta, Roberto Pizzuto, Daniele Annunziata, Salvatore Diagnostics (Basel) Systematic Review The objective of this review was to summarize published radiomics studies dealing with infradiaphragmatic cancers, blood malignancies, melanoma, and musculoskeletal cancers, and assess their quality. PubMed database was searched from January 1990 to February 2022 for articles performing radiomics on PET imaging of at least 1 specified tumor type. Exclusion criteria includd: non-oncological studies; supradiaphragmatic tumors; reviews, comments, cases reports; phantom or animal studies; technical articles without a clinically oriented question; studies including <30 patients in the training cohort. The review database contained PMID, first author, year of publication, cancer type, number of patients, study design, independent validation cohort and objective. This database was completed twice by the same person; discrepant results were resolved by a third reading of the articles. A total of 162 studies met inclusion criteria; 61 (37.7%) studies included >100 patients, 13 (8.0%) were prospective and 61 (37.7%) used an independent validation set. The most represented cancers were esophagus, lymphoma, and cervical cancer (n = 24, n = 24 and n = 19 articles, respectively). Most studies focused on 18F-FDG, and prognostic and response to treatment objectives. Although radiomics and artificial intelligence are technically challenging, new contributions and guidelines help improving research quality over the years and pave the way toward personalized medicine. MDPI 2022-05-27 /pmc/articles/PMC9222024/ /pubmed/35741139 http://dx.doi.org/10.3390/diagnostics12061330 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Systematic Review Morland, David Triumbari, Elizabeth Katherine Anna Boldrini, Luca Gatta, Roberto Pizzuto, Daniele Annunziata, Salvatore Radiomics in Oncological PET Imaging: A Systematic Review—Part 2, Infradiaphragmatic Cancers, Blood Malignancies, Melanoma and Musculoskeletal Cancers |
title | Radiomics in Oncological PET Imaging: A Systematic Review—Part 2, Infradiaphragmatic Cancers, Blood Malignancies, Melanoma and Musculoskeletal Cancers |
title_full | Radiomics in Oncological PET Imaging: A Systematic Review—Part 2, Infradiaphragmatic Cancers, Blood Malignancies, Melanoma and Musculoskeletal Cancers |
title_fullStr | Radiomics in Oncological PET Imaging: A Systematic Review—Part 2, Infradiaphragmatic Cancers, Blood Malignancies, Melanoma and Musculoskeletal Cancers |
title_full_unstemmed | Radiomics in Oncological PET Imaging: A Systematic Review—Part 2, Infradiaphragmatic Cancers, Blood Malignancies, Melanoma and Musculoskeletal Cancers |
title_short | Radiomics in Oncological PET Imaging: A Systematic Review—Part 2, Infradiaphragmatic Cancers, Blood Malignancies, Melanoma and Musculoskeletal Cancers |
title_sort | radiomics in oncological pet imaging: a systematic review—part 2, infradiaphragmatic cancers, blood malignancies, melanoma and musculoskeletal cancers |
topic | Systematic Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9222024/ https://www.ncbi.nlm.nih.gov/pubmed/35741139 http://dx.doi.org/10.3390/diagnostics12061330 |
work_keys_str_mv | AT morlanddavid radiomicsinoncologicalpetimagingasystematicreviewpart2infradiaphragmaticcancersbloodmalignanciesmelanomaandmusculoskeletalcancers AT triumbarielizabethkatherineanna radiomicsinoncologicalpetimagingasystematicreviewpart2infradiaphragmaticcancersbloodmalignanciesmelanomaandmusculoskeletalcancers AT boldriniluca radiomicsinoncologicalpetimagingasystematicreviewpart2infradiaphragmaticcancersbloodmalignanciesmelanomaandmusculoskeletalcancers AT gattaroberto radiomicsinoncologicalpetimagingasystematicreviewpart2infradiaphragmaticcancersbloodmalignanciesmelanomaandmusculoskeletalcancers AT pizzutodaniele radiomicsinoncologicalpetimagingasystematicreviewpart2infradiaphragmaticcancersbloodmalignanciesmelanomaandmusculoskeletalcancers AT annunziatasalvatore radiomicsinoncologicalpetimagingasystematicreviewpart2infradiaphragmaticcancersbloodmalignanciesmelanomaandmusculoskeletalcancers |